(Total Views: 446)
Posted On: 10/20/2020 5:09:42 PM
Post# of 22465
My comment on:
Following the breadcrumbs:
8/13: Quantum signs distribution agreement bundling QDX HealthID solution with Innova Medical Group / Tried and Tested rapid response SARS/COVID-19 antigen test kit
9/29: Biotime shall exclusively manufacture its SARS-CoV-2 rapid antigen test kit under the Innova brand and Innova, the owner of the intellectual property comprising the antigen test kits, shall also be the sole and exclusive distributor and seller of those kits globally and shall have the rights to establish, operate, and maintain sister manufacturing facilities for the antigen tests around the world.
http://www.biotime.cn/En_Ne_d_gci_21_id_63.html
10/15: Innova Medical Group commits $8.1M, leases prime Pasadena office space
10/16: Kansas trial testimony ends with oral closing arguments; judgment pending court’s adjudication of written closing arguments.
10/19: UK secures 20M Innova Tried and Tested 15-minute test kits for rapid deployment to the front lines of the U.K. war on COVID-19
Following the breadcrumbs:
8/13: Quantum signs distribution agreement bundling QDX HealthID solution with Innova Medical Group / Tried and Tested rapid response SARS/COVID-19 antigen test kit
9/29: Biotime shall exclusively manufacture its SARS-CoV-2 rapid antigen test kit under the Innova brand and Innova, the owner of the intellectual property comprising the antigen test kits, shall also be the sole and exclusive distributor and seller of those kits globally and shall have the rights to establish, operate, and maintain sister manufacturing facilities for the antigen tests around the world.
http://www.biotime.cn/En_Ne_d_gci_21_id_63.html
10/15: Innova Medical Group commits $8.1M, leases prime Pasadena office space
10/16: Kansas trial testimony ends with oral closing arguments; judgment pending court’s adjudication of written closing arguments.
10/19: UK secures 20M Innova Tried and Tested 15-minute test kits for rapid deployment to the front lines of the U.K. war on COVID-19
(0)
(0)
